Time trends in biochemical recurrence after radical prostatectomy: Results of the search database

被引:108
作者
Freedland, SJ
Presti, JC
Amling, CL
Kane, CJ
Aronson, WJ
Dorey, F
Terris, MK
机构
[1] Univ Calif Los Angeles, Sch Med, Dept Urol, Los Angeles, CA 90095 USA
[2] Stanford Univ, Sch Med, Dept Urol, Palo Alto, CA 94304 USA
[3] Univ Calif San Francisco, Sch Med, Dept Urol, San Francisco, CA 94143 USA
[4] USN, Med Ctr, Dept Urol, San Diego, CA 92152 USA
[5] Vet Affairs Greater Los Angeles Hlth Care Syst, Dept Surg, Los Angeles, CA USA
[6] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA
[7] Med Coll Georgia, Div Urol, Augusta, GA 30912 USA
关键词
D O I
10.1016/S0090-4295(02)02526-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives. To determine whether in the prostate-specific antigen (PSA) era stage and/or grade migration of patients treated with radical prostatectomy (RP) has occurred. We also examined whether the biochemical recurrence rates after RIP have changed with time. Methods. A total of 1654 patients from the Shared Equal Access Regional Cancer Hospital (SEARCH) database were analyzed for time trends in age, preoperative PSA level, clinical stage, biopsy Gleason score, prostatectomy Gleason grade, pathologic stage, margin status, and recurrence rates after RP. Results were stratified into three 4-year blocks of time between 1988 and 2002 for analysis. Results. The preoperative PSA level, patient age, tumor stage, rate of capsular penetration, and lymph node involvement decreased with time. Both biopsy and pathologic Gleason grade steadily increased with time. The positive margin rate and incidence of seminal vesicle involvement remained stable. On multivariate analysis, only serum PSA level (P <0.001) and biopsy Gleason score (P <0.001) were significant independent predictors of the time to recurrence after RP. The year of surgery was not a significant independent predictor of biochemical recurrence after RP in multivariate analysis. Conclusions. Despite lower stage and lower PSA levels with time, we found no improvement in PSA recurrence rates over time. This may reflect lead-time bias in detecting PSA recurrence by the use of more sensitive PSA assays. in recent years. (C) 2003, Elsevier Science Inc.
引用
收藏
页码:736 / 741
页数:6
相关论文
共 27 条
  • [1] Amling CL, 1998, MAYO CLIN PROC, V73, P401
  • [2] [Anonymous], AM JOINT COMM CANC M
  • [3] Radical retropubic prostatectomy: time trends, morbidity and mortality in Japan
    Arai, Y
    Egawa, S
    Tobisu, K
    Sagiyama, K
    Sumiyoshi, Y
    Hashine, K
    Kawakita, M
    Matsuda, T
    Matsumoto, K
    Fujimoto, H
    Okada, T
    Kakehi, Y
    Terachi, T
    Ogawa, O
    [J]. BJU INTERNATIONAL, 2000, 85 (03) : 287 - 294
  • [4] Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies
    Borboroglu, PG
    Comer, SW
    Riffenburgh, RH
    Amling, CL
    [J]. JOURNAL OF UROLOGY, 2000, 163 (01) : 158 - 162
  • [5] Systematic sextant biopsies in the prediction of extracapsular extension at radical prostatectomy
    Borirakchanyavat, S
    Bhargava, V
    Shinohara, K
    Toke, A
    Carroll, PR
    Presti, JC
    [J]. UROLOGY, 1997, 50 (03) : 373 - 378
  • [6] MEASUREMENT OF PROSTATE-SPECIFIC ANTIGEN IN SERUM AS A SCREENING-TEST FOR PROSTATE-CANCER
    CATALONA, WJ
    SMITH, DS
    RATLIFF, TL
    DODDS, KM
    COPLEN, DE
    YUAN, JJJ
    PETROS, JA
    ANDRIOLE, GL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) : 1156 - 1161
  • [7] DETECTION OF ORGAN-CONFINED PROSTATE-CANCER IS INCREASED THROUGH PROSTATE-SPECIFIC ANTIGEN-BASED SCREENING
    CATALONA, WJ
    SMITH, DS
    RATLIFF, TL
    BASLER, JW
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (08): : 948 - 954
  • [8] CLINICAL-APPLICATION OF TRANS-RECTAL ULTRASONOGRAPHY AND PROSTATE SPECIFIC ANTIGEN IN THE SEARCH FOR PROSTATE-CANCER
    COONER, WH
    MOSLEY, BR
    RUTHERFORD, CL
    BEARD, JH
    POND, HS
    BASS, RB
    TERRY, WJ
    [J]. JOURNAL OF UROLOGY, 1988, 139 (04) : 758 - 761
  • [9] Dennis LK, 2000, PROSTATE, V42, P247
  • [10] Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy - A diagnosis that should not be made
    Epstein, JI
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2000, 24 (04) : 477 - 478